MAPT and Alzheimer disease: Interestingly, Ser-262 is a key residue required for tau-MT binding (Tseng et al., 2008) and, when phosphorylated, a mediator of tau toxicity in a transgenic Drosophila model of AD (Iijima et al., 2010).